IH vs NAMI
iHuman Inc. and Jinxin Technology Holding Company, side by side — 4 fiscal years reported in CNY, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | IH | NAMI |
|---|---|---|
| Revenue | ¥807.0M | ¥413.0M |
| Net income | ¥95.4M | ¥-94.3M |
| Gross margin | 67.9% | 11.0% |
| Net margin | 11.8% | −22.8% |
| Return on equity | 9.8% | −87.4% |
| Diluted EPS | — | −¥0.07 |
| Dividend / share | — | — |
| Payout ratio | 41.0% | — |
| Free cash flow | ¥46.4M | ¥-25.4M |
| Equity | ¥995.2M | ¥83.9M |
| Net debt / equity | — | −0.59× |
| Current ratio | 3.57× | 1.53× |
| Revenue CAGR 5y | 8.7% | — |
| Profit CAGR 5y | — | — |
IH bills 2.0× the revenue of NAMI, and NAMI closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
4 years side by side
| Fiscal year | IH | NAMI |
|---|---|---|
| FY2025 | ¥807.0M | ¥413.0M |
| FY2024 | ¥922.2M | ¥406.4M |
| FY2023 | ¥1.0B | ¥379.8M |
| FY2022 | ¥985.5M | ¥236.4M |
Net income by year
Bottom line
| Fiscal year | IH | NAMI |
|---|---|---|
| FY2025 | ¥95.4M | ¥-94.3M |
| FY2024 | ¥98.6M | ¥20.3M |
| FY2023 | ¥180.9M | ¥70.5M |
| FY2022 | ¥109.8M | ¥52.8M |
Advertisement
AdSense · Rectangle 336×280